The medical polyoxymethylene market was valued at US$ 61,542.14 thousand in 2019 and is projected to reach US$ 88,482.56 thousand by 2028; it is expected to grow at a CAGR of 4.2% from 2020 to 2028.
Polyoxymethylene (POM) is a high-performance engineered thermoplastic, which is traditionally produced through ring opening polymerization of formaldehyde and is mainly supplied in the form of pellets. POM resins are produced by the process of polymerization of formaldehyde so as to provide the homopolymers and copolymers by deploying the other monomers. They are known for its several constructive and mechanical properties which makes them a suitable material to replace metal in production of several medical devices. POM is known to provide metal-like machining properties along with thermal and dimensional stability, ultra-high modulus, enhanced strength, hardness and rigidness, minimal friction coefficient and gas/vapor permeability, dielectric strength, and better retention characteristics at elevated temperature. All such properties make it an ideal material to be used in production of several medical devices and equipment such as dialysis machines, handles for instrument, pharmaceutical closure, inhalers, insulin pens and other such application areas. The growth of the market is strongly driven by advancements in technology along with growth of medical device industry. Rapid urbanization, coupled with economic growth and rise in incidence of chronic ailments and diseases, is further stimulating the demand for medical polyoxymethylene.
In 2019, Asia Pacific contributed to the largest share in the global medical polyoxymethylene market. The growth of the medical polyoxymethylene market in this region is primarily attributed to the presence of strong industrial base along with presence of prominent manufactures significantly contributing to the market growth. Growth of medical sector in the developing countries such as China, Japan, South Korea, and India provide lucrative opportunities for the growth of the medical polyoxymethylene market in Asia Pacific. Further, rapid urbanization, along with rise in incidence of chronic diseases, is also favoring the market growth in the region. The easy accessibility and availability of raw materials, coupled with cheap labor and low production cost, is yet another factor driving the market in the region.
The COVID-19 pandemic is adversely affecting economies and industries in various countries due to government-imposed lockdowns, and travel bans, and business shutdowns. The chemical & materials is one of the major industries suffering serious disruptions such as supply chain breaks, technology events cancellations, and office shutdowns. The shutdown of various plants and factories in North America, Europe, Asia Pacific, South America, and the Middle East & Africa has restricted the global supply chain and negatively impacted the manufacturing activities, delivery schedules, and product sales. Furthermore, various companies have already predicted possible delays in product deliveries and slump in future sales of their products. The travel bans imposed by countries in Europe, Asia, and North America are hindering the business collaborations and partnership opportunities. All these factors are hampering the activities in the chemical & materials industry, which are restraining the growth of various markets related to this industry. Many countries are now resuming to normalcy, whereas many are experiencing second wave of the outbreak. In addition, due to vaccination drives, now the situations are changing across the globe.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Market Insights
Rising Demand from Drug Contact and Delivery Applications
Drug delivery is defined as the process of administering a pharmaceutical compound or drug so as to obtain a therapeutic effect in humans or animals. According to the latest World Drug Report released by the United Nations Office on Drugs and Crime (UNODC), approximately 269 million people consumed drugs globally in 2018, which is a 30% hike since 2009. The COVID-19 pandemic and economic downturn have further triggered drug dangers in health globally. Drug contact and delivery is considered to be one of the highly technical and advanced applications; therefore, manufacturers and end users are looking for high quality materials. Several manufacturers of drug-delivery devices are focused on creating complex products by using high-performance materials with better physical and mechanical features, along with advanced functionality and better aesthetics and ergonomics, which could align with the objective of meeting complexity and cost effectiveness. Hence, to cater to the growing demand, manufacturers have come up with the use of polyoxymethylene (POM) in drug-delivery devices.
An insulin pen is significantly used as a drug delivery device to inject insulin into a diabetic patient. Parts of an insulin pen, such as outer needle cap, pen cap, inner needle cap, and dosage knob, are produced using polyoxymethylene (POM). Use of POM in these parts provides characteristics such as impact resistance along with sterility and minimal moisture absorption. The demand for infusion pump is high in the US, while the demand for insulin pens is high in Europe, China, India, and Brazil, owing to the growing health consciousness among the population. Surge in demand for insulin pen and subsequent rise in its production are expected to proliferate the growth of engineering plastics market such as POM.
Application Insights
Based on application, the global medical polyoxymethylene market is segmented into dialysis machine, handles for surgical instruments, inhalers, insulin pen, and others. The insulin pen segment led the market with the largest share in 2019. The insulin pen segment is considered to be one of the lucrative segments in the medical polyoxymethylene market. Insulin pens are categorized under drug delivery devices, which are easy to use, effective, and quite affordable. These factors have positively impacted the demand for insulin pens across developed and developing economies as many people with diabetes are preferring these pens to administer insulin. The rising number of aging patients, coupled with increasing incidence of diabetes and surging adoption of advance drug delivery methods, is expected to positively affect the demand for insulin pens in the market. Several manufacturers of drug delivery devices are focused on creating complex products by using high-performance materials with better physical and mechanical features, along with advanced functionality and better aesthetics and ergonomics, which could align with the objective of meeting complexity and cost effectiveness. Hence, to cater to the growing demand, manufacturers have come up with the use of polyoxymethylene (POM) in drug delivery devices.
The key players operating in the global medical polyoxymethylene market include Daicel Corporation (Polyplastics Co. Ltd); Celanese Corporation; Dupont De Nemours, Inc.; Korea Engineering Plastics Co. Ltd; and Mitsubishi Chemical Corporation. Major market players are focused on strategies such as mergers and acquisitions and product launches to increase their geographical presence and consumer base globally.
Medical Polyoxymethylene Market Regional Insights
The regional trends and factors influencing the Medical Polyoxymethylene Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Medical Polyoxymethylene Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
- Get the Regional Specific Data for Medical Polyoxymethylene Market
Medical Polyoxymethylene Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 61.54 Million |
Market Size by 2028 | US$ 88.48 Million |
Global CAGR (2019 - 2028) | 4.2% |
Historical Data | 2017-2018 |
Forecast period | 2020-2028 |
Segments Covered |
By Application
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Medical Polyoxymethylene Market Players Density: Understanding Its Impact on Business Dynamics
The Medical Polyoxymethylene Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Medical Polyoxymethylene Market are:
- BASF SE
- Celanese Corporation
- DuPont de Nemours, Inc.
- Ensinger
- Inventro Polymers
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Medical Polyoxymethylene Market top key players overview
Report Spotlights
- Progressive industry trends in the global medical polyoxymethylene market to help players develop effective long-term strategies
- Business growth strategies adopted by developed and developing markets
- Quantitative analysis of the market from 2017 to 2028
- Estimation of the demand for medical polyoxymethylene across various industries
- PEST analysis to illustrate the efficacy of buyers and suppliers operating in the industry to predict market growth
- Recent developments to understand the competitive market scenario and the demand for medical polyoxymethylene
- Market trends and outlook coupled with factors driving and restraining the growth of the medical polyoxymethylene market
- Decision-making process by understanding strategies that underpin commercial interest with regard to global medical polyoxymethylene market growth
- Medical polyoxymethylene market size at various nodes of market
- Detailed overview and segmentation of the global medical polyoxymethylene market as well as its dynamics in the industry
- Medical polyoxymethylene market size in various regions with promising growth opportunities
Medical Polyoxymethylene Market, by Application
- Dialysis Machine
- Handles for Surgical Instruments
- Inhalers
- Insulin Pen
- Others
Company Profiles
- BASF SE
- Celanese Corporation
- DuPont de Nemours, Inc.
- Ensinger
- Inventro Polymers
- Kolon Plastics
- Korea Engineering Plastics Co., Ltd
- LG Chem
- Mitsubishi Chemical Corporation
- Polyplastics Co., Ltd.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russian Federation, Saudi Arabia, South Africa, South Korea, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The inhalers segment is growing at a faster pace in the market during the forecast period. Polyacetal or polyoxymethylene (POM) is formaldehyde-based and semi-crystalline form of thermoplastics, with characteristics such as better strength and rigidity and firmness, along with moldability, enhanced mechanical properties, and abrasion, fatigue, and chemical resistance. Owing to all these properties, it is significantly used as a construction material and in designing medical equipment. The cumulative scope of characteristics possessed by such thermoplastics makes them ideal to be used across diversified application bases including dry powder inhalers and metered dose inhalers (MDIs). Cipla, which is considered to be one of the market leaders of respiratory therapies, has reported that post COVID-19 pandemic, there would be a surge in demand for respiratory drugs and inhalers, owing to after-effects of COVID-19 disease. Hence, it is quite evident that the demand for inhalers is set to rise, which may channelize the need for polyoxymethylene (POM). Further, manufacturers such as Vanéflon NV are involved in the production and supply of polyacetal for medical applications such as metered dose inhalers.
The major players operating in the global Medical Polyoxymethylene market are BASF SE, DuPont de Nemours, Inc., Ensinger, Inventro Polymers, Korea Engineering Plastics Co., Ltd., LG Chem, Mitsubishi Chemical Corporation, Polyplastics Group, Celanese, and Kolon Plastics are among many others.
Asia pacific is considered to be dominating region in global medical polyoxymethylene market. The Medical Polyoxymethylene industry in the countries of APAC has experienced a considerable shift over the years. The massive growth of the Asia-Pacific region market is due to the rising investment in advanced healthcare facilities and infrastructure in emerging economies, such as India and China. The robust manufacturing base of the engineered plastics in China, Japan, and India, high demand for polyoxymethylene in various application bases are expected to augment regional market growth. Furthermore, favorable policies implemented by the government of India and Make in India, are expected to create sufficient growth opportunities for the healthcare industry, which, in turn, is expected to increase the consumption of medical polyoxymethylene in the region. The dominance is attributable to the rising prevalence of diseases such as diabetes along with rapid growth of healthcare industry. Further, the shift in consumer lifestyle and growing focus towards health are other factors driving the demand for medical polyoxymethylene in the economy.
Trends and growth analysis reports related to Chemicals and Materials : READ MORE..
The List of Companies - Medical POM Market
- BASF SE
- Celanese Corporation
- DuPont de Nemours, Inc.
- Ensinger
- Inventro Polymers
- Kolon Plastics
- Korea Engineering Plastics Co., Ltd
- LG Chem
- Mitsubishi Chemical Corporation
- Polyplastics Co., Ltd.